TY - JOUR
T1 - Artificial Intelligence in Aptamer–Target Binding Prediction
AU - Chen, Zihao
AU - Hu, Long
AU - Zhang, Bao-Ting
AU - Lu, Aiping
AU - Wang, Yaofeng
AU - Yu, Yuanyuan
AU - Zhang, Ge
N1 - Funding Information:
This study was supported by the National Key R&D Program of the Ministry of Science and Technology of China (grant number 2018YFA0800800), the Hong Kong General Research Fund of the Research Grants Council of the Hong Kong Special Administrative Region, China (grant number 12102120), the Theme?based Research Scheme of the Research Grants Council of the Hong Kong Special Administrative Region, China (grant number T12?201/20?R), the Basic and Applied Basic Research Fund of the Department of Science and Technology of the Guangdong Province (grant number 2019B1515120089), and the Interinstitutional Collaborative Research Scheme of Hong Kong Baptist University (grant number RC?ICRS/19?20/01).
Publisher copyright:
© 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Aptamers are short single‐stranded DNA, RNA, or synthetic Xeno nucleic acids (XNA) molecules that can interact with corresponding targets with high affinity. Owing to their unique features, including low cost of production, easy chemical modification, high thermal stability, re-producibility, as well as low levels of immunogenicity and toxicity, aptamers can be used as an alternative to antibodies in diagnostics and therapeutics. Systematic evolution of ligands by exponential enrichment (SELEX), an experimental approach for aptamer screening, allows the selection and identification of in vitro aptamers with high affinity and specificity. However, the SELEX pro-cess is time consuming and characterization of the representative aptamer candidates from SELEX is rather laborious. Artificial intelligence (AI) could help to rapidly identify the potential aptamer candidates from a vast number of sequences. This review discusses the advancements of AI pipe-lines/methods, including structure‐based and machine/deep learning‐based methods, for predicting the binding ability of aptamers to targets. Structure‐based methods are the most used in com-puter‐aided drug design. For this part, we review the secondary and tertiary structure prediction methods for aptamers, molecular docking, as well as molecular dynamic simulation methods for aptamer–target binding. We also performed analysis to compare the accuracy of different secondary and tertiary structure prediction methods for aptamers. On the other hand, advanced machine‐ /deep‐learning models have witnessed successes in predicting the binding abilities between targets and ligands in drug discovery and thus potentially offer a robust and accurate approach to predict the binding between aptamers and targets. The research utilizing machine‐/deep‐learning techniques for prediction of aptamer–target binding is limited currently. Therefore, perspectives for models, algorithms, and implementation strategies of machine/deep learning‐based methods are discussed. This review could facilitate the development and application of high‐throughput and less laborious in silico methods in aptamer selection and characterization.
AB - Aptamers are short single‐stranded DNA, RNA, or synthetic Xeno nucleic acids (XNA) molecules that can interact with corresponding targets with high affinity. Owing to their unique features, including low cost of production, easy chemical modification, high thermal stability, re-producibility, as well as low levels of immunogenicity and toxicity, aptamers can be used as an alternative to antibodies in diagnostics and therapeutics. Systematic evolution of ligands by exponential enrichment (SELEX), an experimental approach for aptamer screening, allows the selection and identification of in vitro aptamers with high affinity and specificity. However, the SELEX pro-cess is time consuming and characterization of the representative aptamer candidates from SELEX is rather laborious. Artificial intelligence (AI) could help to rapidly identify the potential aptamer candidates from a vast number of sequences. This review discusses the advancements of AI pipe-lines/methods, including structure‐based and machine/deep learning‐based methods, for predicting the binding ability of aptamers to targets. Structure‐based methods are the most used in com-puter‐aided drug design. For this part, we review the secondary and tertiary structure prediction methods for aptamers, molecular docking, as well as molecular dynamic simulation methods for aptamer–target binding. We also performed analysis to compare the accuracy of different secondary and tertiary structure prediction methods for aptamers. On the other hand, advanced machine‐ /deep‐learning models have witnessed successes in predicting the binding abilities between targets and ligands in drug discovery and thus potentially offer a robust and accurate approach to predict the binding between aptamers and targets. The research utilizing machine‐/deep‐learning techniques for prediction of aptamer–target binding is limited currently. Therefore, perspectives for models, algorithms, and implementation strategies of machine/deep learning‐based methods are discussed. This review could facilitate the development and application of high‐throughput and less laborious in silico methods in aptamer selection and characterization.
KW - Aptamer
KW - Artificial intelligence
KW - Binding
KW - Deep learning
KW - Machine learning
KW - SELEX
KW - Structure prediction
UR - http://www.scopus.com/inward/record.url?scp=85103178481&partnerID=8YFLogxK
U2 - 10.3390/ijms22073605
DO - 10.3390/ijms22073605
M3 - Review article
C2 - 33808496
AN - SCOPUS:85103178481
SN - 1661-6596
VL - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 7
M1 - 3605
ER -